{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:26:32Z","timestamp":1761513992511},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T00:00:00Z","timestamp":1492560000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00066-017-1130-0","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T13:26:54Z","timestamp":1492608414000},"page":"515-524","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage\u00a0I disease"],"prefix":"10.1007","volume":"193","author":[{"given":"Carsten","family":"Nieder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"De Ruysscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie E.","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minesh P.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Sahgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,19]]},"reference":[{"key":"1130_CR1","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.prro.2013.05.002","volume":"4","author":"FM Kong","year":"2014","unstructured":"Kong FM, Cuneo KC, Wang L et al (2014) Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation Oncology. Pract Radiat Oncol 4:e133\u2013141","journal-title":"Pract Radiat Oncol"},{"key":"1130_CR2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00066-014-0739-5","volume":"191","author":"DH Schanne","year":"2015","unstructured":"Schanne DH, Nestle U, Allg\u00e4uer M et\u00a0al (2015) Stereotactic body radiotherapy for centrally located stage I NSCLC: a\u00a0multicenter analysis. Strahlenther Onkol 191:125\u2013132","journal-title":"Strahlenther Onkol"},{"key":"1130_CR3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13014-015-0423-7","volume":"10","author":"KD Kelley","year":"2015","unstructured":"Kelley KD, Benninghoff DL, Stein JS et\u00a0al (2015) Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy. Radiat Oncol 10:120","journal-title":"Radiat Oncol"},{"key":"1130_CR4","first-page":"148","volume":"3","author":"C Nieder","year":"2015","unstructured":"Nieder C, Andratschke NH, Guckenberger M (2015) A pooled analysis of stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small cell lung cancer: is failure to recruit patients into randomized trials also an answer to the research question? Ann Transl Med 3:148","journal-title":"Ann Transl Med"},{"key":"1130_CR5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","volume":"16","author":"JY Chang","year":"2015","unstructured":"Chang JY, Senan S, Paul MA et al (2015) Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a\u00a0pooled analysis of two randomised trials. Lancet Oncol 16:630\u2013637","journal-title":"Lancet Oncol"},{"key":"1130_CR6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.lungcan.2015.07.009","volume":"90","author":"N Shaverdian","year":"2015","unstructured":"Shaverdian N, Wang PC, Steinberg M, Lee P (2015) The patient\u2019s perspective on stereotactic body radiation therapy (SBRT) vs. surgery for treatment of early stage non-small cell lung cancer (NSCLC). Lung Cancer 90:230\u2013233","journal-title":"Lung Cancer"},{"key":"1130_CR7","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/JTO.0b013e3182992421","volume":"8","author":"F Farjah","year":"2013","unstructured":"Farjah F, Lou F, Sima C, Rusch VW, Rizk NP (2013) A prediction model for pathologic N2 disease in lung cancer patients with a\u00a0negative mediastinum by positron emission tomography. J\u00a0Thorac Oncol 8:1170\u20131180","journal-title":"J Thorac Oncol"},{"key":"1130_CR8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fonc.2012.00208","volume":"2","author":"J Cuaron","year":"2013","unstructured":"Cuaron J, Dunphy M, Rimner A (2013) Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer. Front Oncol 2:208","journal-title":"Front Oncol"},{"key":"1130_CR9","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/cncr.20539","volume":"101","author":"H Onishi","year":"2004","unstructured":"Onishi H, Araki T, Shirato H et al (2004) Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a\u00a0Japanese multi-institutional study. Cancer 101:1623\u20131631","journal-title":"Cancer"},{"key":"1130_CR10","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ijrobp.2009.07.1751","volume":"81","author":"H Onishi","year":"2011","unstructured":"Onishi H, Shirato H, Nagata Y et al (2011) Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 81:1352\u20131358","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1130_CR11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.prro.2011.10.004","volume":"2","author":"N Mehta","year":"2012","unstructured":"Mehta N, King CR, Agazaryan N et al (2012) Stereotactic body radiation therapy and 3\u2011dimensional conformal radiotherapy for stage I non-small cell lung cancer: a\u00a0pooled analysis of biological equivalent dose and local control. Pract Radiat Oncol 2:288\u2013295","journal-title":"Pract Radiat Oncol"},{"key":"1130_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.lungcan.2015.01.005","volume":"87","author":"S Mokhles","year":"2015","unstructured":"Mokhles S, Verstegen N, Maat AP et al (2015) Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: results from propensity score analysis. Lung Cancer 87:283\u2013289","journal-title":"Lung Cancer"},{"key":"1130_CR13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3747\/co.22.2526","volume":"22","author":"R VanderMeer","year":"2015","unstructured":"VanderMeer R, Chambers S, Van Dam A, Cutz JC, Goffin JR, Ellis PM (2015) Diagnosing lung cancer in the 21st century: are we ready to meet the challenge of individualized care? Curr Oncol 22:272\u2013278","journal-title":"Curr Oncol"},{"key":"1130_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijrobp.2015.01.045","volume":"92","author":"NM Woody","year":"2015","unstructured":"Woody NM, Stephans KL, Marwaha G, Djemil T, Videtic GM (2015) Stereotactic body radiation therapy for non-small cell lung cancer tumors greater than 5\u202fcm: Safety and efficacy. Int J Radiat Oncol Biol Phys 92:325\u2013331","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1130_CR15","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S1470-2045(12)70242-5","volume":"13","author":"S Senthi","year":"2012","unstructured":"Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S (2012) Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a\u00a0retrospective analysis. Lancet Oncol 13:802\u2013809","journal-title":"Lancet Oncol"},{"key":"1130_CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cllc.2015.09.006","volume":"17","author":"DE Spratt","year":"2016","unstructured":"Spratt DE, Wu AJ, Adeseye V et al (2016) Recurrence patterns and second primary lung cancers after stereotactic body radiotherapy for early-stage non-small cell lung cancer: implications for surveillance. Clin Lung Cancer 17:177\u2013183","journal-title":"Clin Lung Cancer"},{"key":"1130_CR17","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/JTO.0000000000000483","volume":"10","author":"LL Berg Van den","year":"2015","unstructured":"Van den Berg LL, Klinkenberg TJ, Groen HJ, Widder J (2015) Patterns of recurrence and survival after surgery or stereotactic radiotherapy for early stage NSCLC. J\u00a0Thorac Oncol 10:826\u2013831","journal-title":"J Thorac Oncol"},{"key":"1130_CR18","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.jtho.2016.05.003","volume":"11","author":"MC Ward","year":"2016","unstructured":"Ward MC, Oh SC, Pham YD et\u00a0al (2016) Isolated nodal failure after stereotactic body radiotherapy for lung cancer: the role for salvage mediastinal radiotherapy. J\u00a0Thorac Oncol 11:1558\u20131564","journal-title":"J Thorac Oncol"},{"key":"1130_CR19","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/JTO.0000000000000576","volume":"10","author":"NE Verstegen","year":"2015","unstructured":"Verstegen NE, Lagerwaard FJ, Hashemi SM, Dahele M, Slotman BJ, Senan S (2015) Patterns of disease recurrence after SABR for early stage non-small-cell lung cancer: optimizing follow-up schedules for salvage therapy. J\u00a0Thorac Oncol 10:1195\u20131200","journal-title":"J Thorac Oncol"},{"key":"1130_CR20","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1097\/JTO.0000000000000662","volume":"10","author":"M Hamaji","year":"2015","unstructured":"Hamaji M, Chen F, Matsuo Y, Ueki N, Hiraoka M, Date H (2015) Treatment and prognosis of isolated local relapse after stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: importance of salvage surgery. J\u00a0Thorac Oncol 10:1616\u20131624","journal-title":"J Thorac Oncol"},{"key":"1130_CR21","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ijrobp.2015.02.048","volume":"92","author":"C Oberije","year":"2015","unstructured":"Oberije C, De Ruysscher D, Houben R et al (2015) A validated prediction model for overall survival from stage III non-small cell lung cancer: toward survival prediction for individual patients. Int J Radiat Oncol Biol Phys 92:935\u2013944","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1130_CR22","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/annonc\/mdv187","volume":"26","author":"WE Eberhardt","year":"2015","unstructured":"Eberhardt WE, De Ruysscher D, Weder W et al (2015) 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer. Ann Oncol 26:1573\u20131588","journal-title":"Ann Oncol"},{"key":"1130_CR23","first-page":"706","volume":"28","author":"JY Chang","year":"2014","unstructured":"Chang JY, Kestin LL, Barriger RB et al (2014) ACR Appropriateness Criteria\u00ae nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status\/definitive intent. Oncology 28:706\u2013710","journal-title":"Oncology"},{"key":"1130_CR24","doi-asserted-by":"crossref","first-page":"e314S","DOI":"10.1378\/chest.12-2360","volume":"143","author":"N Ramnath","year":"2013","unstructured":"Ramnath N, Dilling TJ, Harris LJ et al (2013) Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e314S\u2013340S","journal-title":"Chest"},{"key":"1130_CR25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/COC.0000000000000154","volume":"38","author":"H Willers","year":"2015","unstructured":"Willers H, Stinchcombe TE, Barriger RB et al (2015) ACR Appropriateness Criteria(\u00ae) induction and adjuvant therapy for N2 non-small-cell lung cancer. Am J Clin Oncol 38:197\u2013205","journal-title":"Am J Clin Oncol"},{"key":"1130_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.prro.2015.02.012","volume":"5","author":"G Rodrigues","year":"2015","unstructured":"Rodrigues G, Choy H, Bradley J et al (2015) Definitive radiation therapy in locally advanced non-small cell lung cancer: executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. Pract Radiat Oncol 5:141\u2013148","journal-title":"Pract Radiat Oncol"},{"key":"1130_CR27","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1200\/JCO.2014.59.2360","volume":"33","author":"A Bezjak","year":"2015","unstructured":"Bezjak A, Temin S, Franklin G et al (2015) Definitive and adjuvant radiotherapy in locally advanced non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline endorsement of the American Society for Radiation Oncology evidence-based clinical practice guideline. J\u00a0Clin Oncol 33:2100\u20132105","journal-title":"J Clin Oncol"},{"key":"1130_CR28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"JD Bradley","year":"2015","unstructured":"Bradley JD, Paulus R, Komaki R et al (2015) Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a\u00a0randomised, two-by-two factorial phase 3 study. Lancet Oncol 16:187\u2013199","journal-title":"Lancet Oncol"},{"key":"1130_CR29","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/annonc\/mdr565","volume":"23","author":"SI Jalal","year":"2012","unstructured":"Jalal SI, Riggs HD, Melnyk A et al (2012) Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a\u00a0phase III trial from the Hoosier Oncology Group (HOG) and US Oncology. Ann Oncol 23:1730\u20131738","journal-title":"Ann Oncol"},{"key":"1130_CR30","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1016\/S1470-2045(14)70345-6","volume":"15","author":"D Ruysscher De","year":"2014","unstructured":"De Ruysscher D, Faivre-Finn C, Le Pechoux C, Peeters S, Belderbos J (2014) High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer. Lancet Oncol 15:e620\u2013e624","journal-title":"Lancet Oncol"},{"key":"1130_CR31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/COC.0b013e31826b9950","volume":"37","author":"TJ Kruser","year":"2014","unstructured":"Kruser TJ, McCabe BP, Mehta MP et al (2014) Reirradiation for locoregionally recurrent lung cancer: outcomes in small cell and non-small cell lung carcinoma. Am J Clin Oncol 37:70\u201376","journal-title":"Am J Clin Oncol"},{"key":"1130_CR32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1748-717X-9-210","volume":"9","author":"A Amini","year":"2014","unstructured":"Amini A, Yeh N, Gaspar LE, Kavanagh B, Karam SD (2014) Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a\u00a0review. Radiat Oncol 9:210","journal-title":"Radiat Oncol"},{"key":"1130_CR33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13566-014-0175-2","volume":"4","author":"NR Patel","year":"2015","unstructured":"Patel NR, Lanciano R, Sura K et al (2015) Stereotactic body radiotherapy for re-irradiation of lung cancer recurrence with lower biological effective doses. J\u00a0Radiat Oncol 4:65\u201370","journal-title":"J Radiat Oncol"},{"key":"1130_CR34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2013.02.002","volume":"106","author":"JD Evans","year":"2013","unstructured":"Evans JD, Gomez DR, Amini A et\u00a0al (2013) Aortic dose constraints when reirradiating thoracic tumors. Radiother Oncol 106:327\u2013332","journal-title":"Radiother Oncol"},{"key":"1130_CR35","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.radonc.2011.09.012","volume":"101","author":"H Peulen","year":"2011","unstructured":"Peulen H, Karlsson K, Lindberg K et\u00a0al (2011) Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy. Radiother Oncol 101:260\u2013266","journal-title":"Radiother Oncol"},{"key":"1130_CR36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.radonc.2013.11.017","volume":"110","author":"JM Kilburn","year":"2014","unstructured":"Kilburn JM, Kuremsky JG, Blackstock AW et al (2014) Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment. Radiother Oncol 110:505\u2013510","journal-title":"Radiother Oncol"},{"key":"1130_CR37","doi-asserted-by":"crossref","first-page":"15690","DOI":"10.18632\/oncotarget.3704","volume":"6","author":"MB Meng","year":"2015","unstructured":"Meng MB, Wang HH, Zaorsky NG et al (2015) Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer. Oncotarget 6:15690\u201315703","journal-title":"Oncotarget"},{"key":"1130_CR38","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/JTO.0000000000000086","volume":"9","author":"JM Kilburn","year":"2014","unstructured":"Kilburn JM, Lester SC, Lucas JT Jr et al (2014) Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I\/II non-small-cell lung cancer. J\u00a0Thorac Oncol 9:572\u2013576","journal-title":"J Thorac Oncol"},{"key":"1130_CR39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00066-016-1063-z","volume":"193","author":"F Oskan","year":"2017","unstructured":"Oskan F, Becker G, Bleif M (2017) Specific toxicity after stereotactic body radiation therapy to the central chest: a\u00a0comprehensive review. Strahlenther Onkol 193:173\u2013184","journal-title":"Strahlenther Onkol"},{"key":"1130_CR40","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ijrobp.2015.12.007","volume":"94","author":"MS Binkley","year":"2016","unstructured":"Binkley MS, Hiniker SM, Chaudhuri A et\u00a0al (2016) Dosimetric factors and toxicity in highly conformal thoracic reirradiation. Int J Radiat Oncol Biol Phys 94:808\u2013815","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1130_CR41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13014-016-0673-z","volume":"11","author":"K Sumita","year":"2016","unstructured":"Sumita K, Harada H, Asakura H et al (2016) Re-irradiation for locoregionally recurrent tumors of the thorax: a\u00a0single-institution, retrospective study. Radiat Oncol 11:104","journal-title":"Radiat Oncol"},{"key":"1130_CR42","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/bjc.2013.466","volume":"109","author":"HH Str\u00f8m","year":"2013","unstructured":"Str\u00f8m HH, Bremnes RM, Sundstr\u00f8m SH, Helbekkmo N, Fl\u00f8tten O, Aaseb\u00f8 U (2013) Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a\u00a0randomized trial by the Norwegian Lung Cancer Study Group. Br J Cancer 109:1467\u20131475","journal-title":"Br J Cancer"},{"key":"1130_CR43","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/JTO.0b013e3182429682","volume":"7","author":"M Machtay","year":"2012","unstructured":"Machtay M, Paulus R, Moughan J et al (2012) Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma. J\u00a0Thorac Oncol 7:716\u2013722","journal-title":"J Thorac Oncol"},{"key":"1130_CR44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1748-717X-9-187","volume":"9","author":"RS Rajpara","year":"2014","unstructured":"Rajpara RS, Schreibmann E, Fox T et al (2014) Locoregional tumor failure after definitive radiation for patients with stage III non-small cell lung cancer. Radiat Oncol 9:187","journal-title":"Radiat Oncol"},{"key":"1130_CR45","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1200\/JCO.2010.30.3271","volume":"28","author":"D Ruysscher De","year":"2010","unstructured":"De Ruysscher D, Faivre-Finn C, Nestle U et al (2010) European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J\u00a0Clin Oncol 28:5301\u20135310","journal-title":"J Clin Oncol"},{"key":"1130_CR46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fonc.2013.00176","volume":"3","author":"C Nieder","year":"2013","unstructured":"Nieder C, Pawinski A, Andratschke NH (2013) Combined radio- and chemotherapy for non-small cell lung cancer: systematic review of landmark studies based on acquired citations. Front Oncol 3:176","journal-title":"Front Oncol"},{"key":"1130_CR47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13014-015-0485-6","volume":"10","author":"J Fleckenstein","year":"2015","unstructured":"Fleckenstein J, Eschler A, Kremp K, Kremp S, R\u00fcbe C (2015) Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis. Radiat Oncol 10:178","journal-title":"Radiat Oncol"},{"key":"1130_CR48","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00066-016-0941-8","volume":"192","author":"M Flentje","year":"2016","unstructured":"Flentje M, Huber RM, Engel-Riedel W et al (2016) GILT \u2013 a randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancer. Strahlenther Onkol 192:216\u2013222","journal-title":"Strahlenther Onkol"},{"key":"1130_CR49","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00066-016-0985-9","volume":"192","author":"SU Lee","year":"2016","unstructured":"Lee SU, Moon SH, Cho KH et al (2016) Ablative dose proton beam therapy for stage\u00a0I and recurrent non-small cell lung carcinomas: Ablative dose PBT for NSCLC. Strahlenther Onkol 192:649\u2013657","journal-title":"Strahlenther Onkol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-017-1130-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-017-1130-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-017-1130-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T14:01:28Z","timestamp":1498140088000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-017-1130-0"}},"subtitle":["A\u00a0multi-institutional treatment recommendation"],"short-title":[],"issued":{"date-parts":[[2017,4,19]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1007\/s00066-017-1130-0","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,19]]}}}